|
Crocs Inc., up $1.76 at $17.01 A Sterne Agee analyst reiterated his "Buy" rating on the footwear maker's stock, saying there's still demand for its new styles. Exelixis Inc., up $1.45 at $7.44 A trial of the biotechnology company's experimental drug found that it increased survival time of patients with thyroid cancer. Affymax Inc., up 17 cents at $5.28 The biotech drugmaker said that the Food and Drug Administration has scheduled a meeting to review its experimental anemia drug.
Copyright 2011 The Associated
Press. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
News | Sports | Business | Rural Review | Teaching & Learning | Home and Family | Tourism | Obituaries
Community |
Perspectives
|
Law & Courts |
Leisure Time
|
Spiritual Life |
Health & Fitness |
Teen Scene
Calendar
|
Letters to the Editor